Effectiveness of a new means of etiotropic therapy of mastits in cows during the lactation period
Keywords:lactating cows, clinical and subclinical mastitis, milk, ensitivity of microorganisms, benzylpenicillin, therapeutic efficacy
The aim: is to study the therapeutic effectiveness of the new veterinary medicinal product Revozyn RTU 400 mg/ml (suspension for injections), manufactured by Eurovet Animal Health B.V. (Netherlands), in the treatment of acute (clinical) and hidden (subclinical) mastitis in cows during lactation.
Materials and methods. The research was conducted on dairy cows of the Simmental breed with a milk productivity of 6000-6500 kg of milk per lactation (F "Pchany-Denkovich", Pchany village, Stryi district, Lviv region). To confirm the diagnosis of "acute mastitis" and to identify cows with hidden (subclinical) mastitis, as well as to establish the effectiveness of the researched drug after treatment, a sample was taken with the California Mastitis Test (CMT), manufactured by Bayer Animal Health GmbH, Germany. For bacteriological research, milk samples were taken from the affected quarters of the mammary gland (1 sample from each cow) in compliance with generally accepted sanitary rules. The sensitivity of bacterial isolates to the drug was determined by diffusion in agar using standard discs with benzylpenicillin.
Results. A clinical examination of 127 Simmental dairy cows of different periods of lactation was carried out. During the clinical-diagnostic examination of animals, 8 cows with clinically pronounced, acute course of mastitis were found. According to the nature of the exudate in 3 cows, mastitis was serous, in 5 cows it was purulent-catarrhal. For serous mastitis, the CM test gave a positive result – thickening, the milk solution looks like a gel. In case of purulent catarrh, a sample with the CMT gave a strongly positive result – the mixture thickened, the gel took on a certain shape and became very viscous. The CMT revealed 12 cows with suspected latent mastitis. Representatives of opportunistic microflora – Streptococcus agalactiae, Staphylococcus aureus, and Escherichia coli bacteria were isolated and identified from mastitis milk. The summarized results of the clinical trial of the drugs Revozyn RTU 400 mg/ml and Procillin® 30 % on cows suffering from the clinical form of mastitis were as follows. On the 10th day of the experiment, a milk sample with the California mastitis test showed that all milk samples from cows of both groups (with the exception of one milk sample from a cow from the control group) gave a negative result (the solution remained liquid, blue or gray and homogeneous, without clots). Taking into account the results of the CMT and the number of somatic cells in the milk after the therapy, the therapeutic effectiveness of the veterinary medicinal product Revozyn RTU 400 mg/ml in the treatment of various forms of mastitis in lactating cows was 100 %, and the one of the comparative drug Procillin® 30 % was 83.3 % .
Conclusions. A clinical study of the veterinary medicinal product Revozyn RTU 400 mg/ml, suspension for injections, manufactured by Eurovet Animal Health B.V. (Netherlands) established its effectiveness in the dosage, recommended by the manufacturer, in the treatment of clinical and subclinical mastitis in lactating cows, caused by microorganisms sensitive to benzylpenicillin. In terms of therapeutic effectiveness, the drug Revozyn RTU 400 mg/ml was not inferior to the comparative drug Procillin® 30 % in its dosage form and active substance when used in the treatment of various forms of mastitis in lactating cows
- Gomes, F., Henriques, M. (2015). Control of Bovine Mastitis: Old and Recent Therapeutic Approaches. Current Microbiology, 72 (4), 377–382. doi: https://doi.org/10.1007/s00284-015-0958-8
- Hogeveen, H., Steeneveld, W., Wolf, C. A. (2019). Production Diseases Reduce the Efficiency of Dairy Production: A Review of the Results, Methods, and Approaches Regarding the Economics of Mastitis. Annual Review of Resource Economics, 11 (1), 289–312. doi: https://doi.org/10.1146/annurev-resource-100518-093954
- Zhao, X., Lacasse, P. (2008). Mammary tissue damage during bovine mastitis: Causes and control1. Journal of Animal Science, 86 (suppl_13), 57–65. doi: https://doi.org/10.2527/jas.2007-0302
- Kartashova, V. M., Ivashura, A. I. (1988). Mastity korov. Moscow: Agropromizdat, 256.
- Buragohein, J., Dutta, G. N. (1990). Susceptibility of bovine subclinical mastitis organisms to different antimicrobial agents and treatment. Journal of Animal and Plant Sciences, 60 (5), 550–555.
- Francis, P. G. (1989). Update on mastitis. III. Mastitis therapy. British Veterinary Journal, 145 (4), 302–311. doi: https://doi.org/10.1016/0007-1935(89)90027-4
- Bramley, A. J. (1984). Streptococcus uberis udder infection – a major barrier to reducing mastitis incidence. British Veterinary Journal, 140 (4), 328–335. doi: https://doi.org/10.1016/0007-1935(84)90122-2
- Bogni, C., Odierno, L., Raspanti, C. et al.; Mendez-Vilas, A. (Ed.) (2011). War against mastitis: current concepts on controlling bovine mastitis pathogens. Science against microbial pathogens: communicafing current research and technological advances. Badajoz: Formatex Research Center, 483–494.
- Kibebew, K. (2017). Bovine mastitis: A review of causes and epidemiological point of view. Journal of Biology, Agriculture and Healthcare, 7, 1–14.
- Rainard, P., Foucras, G., Fitzgerald, J. R., Watts, J. L., Koop, G., Middleton, J. R. (2017). Knowledge gaps and research priorities inStaphylococcus aureusmastitis control. Transboundary and Emerging Diseases, 65, 149–165. doi: https://doi.org/10.1111/tbed.12698
- Duse, A., Persson-Waller, K., Pedersen, K. (2021). Microbial Aetiology, Antibiotic Susceptibility and Pathogen-Specific Risk Factors for Udder Pathogens from Clinical Mastitis in Dairy Cows. Animals, 11 (7), 2113. doi: https://doi.org/10.3390/ani11072113
- Owens, W. E., Watts, J. L., Boddie, R. L., Nickerson, S. C. (1988). Antibiotic Treatment of Mastitis: Comparison of Intramammary and Intramammary Plus Intramuscular Therapies. Journal of Dairy Science, 71 (11), 3143–3147. doi: https://doi.org/10.3168/jds.s0022-0302(88)79915-4
- Ivashura, A. I. (1970). Antibiotikoterapiia pri mastitakh u korov. Veterinariia, 8, 91–92.
- Austin, F. H. (1983). Intramammary antibiotic efficacy. Irish. Yeter. New, 5, 2–5.
- Fox, L. K., Hancock, D. D., Weems, C. W., Toma, W., Chang, E. (1987). The Effect of Intramammary Antibiotic Therapy at Calving on Udder Health Traits. Journal of Dairy Science, 70 (8), 1696–1700. doi: https://doi.org/10.3168/jds.s0022-0302(87)80198-4
- Dholakia, P. M., Purohit, J. H., Shah, N. M., Kher, N. N. (1987). In vitro drug sensitivy of bacteria isolated from cases of mastitis in dairy cattle. Jnd. Veter. J., 64 (11), 908–910.
- Soldatov, A. P., Ostroukhova, V. I., Dubinskaia, N. I. (1992). Selektciia molochnogo skota na ustoichivost k mastitu. Selskokhoziaistvennaia biologiia, 6, 18–26.
- Faraji, M. F. (1981). Antibiotic resistance of pathogenic staphylococci and streptococci isolated from cow udder secretion. animals and obtaining high quality livestock products. Moscow, 63–66.
- Hossain, M., Paul, S., Hossain, M., Islam, M., Alam, M. (2017). Bovine Mastitis and Its Therapeutic Strategy Doing Antibiotic Sensitivity Test. Austin Journal of Veterinary Science & Animal Husbandry, 4 (1). doi: https://doi.org/10.26420/austinjvetscianimhusb.2017.1030
- Du Preez, J. H. (2000). Bovine mastitis therapy and why it fails : continuing education. Journal of the South African Veterinary Association, 71 (3), 201–208. doi: https://doi.org/10.4102/jsava.v71i3.714
- Horbatyuk, B. I. (2004). Metodychni rekomendatsiyi do laboratornykh zanyat diahnostyky ta doslidzhennya zahalʹnoho stanu orhanizmu tvaryny. Lviv, 72.
- DSTU ISO 707-2002 Moloko ta molochni produkty. Nastanovy z vidbyrannya prob .
- Kravtsiv, R. Y., Zakhariv, O. Ya., Semeniuk, V. I., Turko, I. B. (2008). Veterynarna mikrobiolohiia. Posibnyk dlia vyshchykh navchalnykh zakladiv. Lviv: Lvivskyi natsionalnyi universytet veterynarnoi medytsyny ta biotekhnolohii imeni S. Z. Hzhytskoho, 418.
- Holovko, A. N., Ushkalov, V. A., Skrypnyk, V. H. et al.; Holovko, A. N. (Ed.) (2007). Mykrobyolohycheskye y vyrusolohycheskye yssledovanyya v veterynarnoy medytsyne. Kharkiv: NTMH, 512.
- DSTU 7357:2013 Moloko ta molochni produkty. Metody mikrobiolohichnoho kontrolyuvannya.
- Metodychni vkazivky po vyznachennyu chutlyvosti mikroorhanizmiv do antymikrobnykh preparativ metodom dyfuziyi v ahar za dopomohoyu standartnykh dyskiv z antybiotykamy (zatverdzheni naukovo-metodychnoyu radoyu DKVM Ukrayiny vid 20.12.2007 r.) (2010). Lviv, 12.
- Papich, M. G. (1987). The beta-lactam antibiotics: clinical pharmacology and recent developments. Compend Contin Educ Pract Vet, 9 (1), 68–74.
- Wright, A. J., Wilkowski, C. J. (1983). The penicillins. Mayo Clin Proc, 58 21–32.
- Barragry, T. B. (1994). Veterinary drug therapy. Baltimore: Lea & Febiger, 224-6, 701–10.
How to Cite
Copyright (c) 2023 Taras Stetsko, Larysa Ostrovska, Yevhen Kostyschyn, Orest Katsaraba, Lidiia-Mariia Kostyshyn, Dmytro Morozenko
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.